Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
Ming-xiao Zhang, Jiali Wang, Chengqiang Mo, et al.
Oncogene (2022) Vol. 41, Iss. 33, pp. 3979-3990
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
Juan Jin, Yuhao Xie, Jin-Shi Zhang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100929-100929
Open Access | Times Cited: 84
The function and mechanisms of action of circular RNAs in Urologic Cancer
Zi-Hao Zhang, Yue Wang, Ya Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 53
A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway
Bo Huang, Junwu Ren, Qiang Ma, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
Nan Zhang, Xinjia Wang, Yu Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
CircUSP1 as a novel marker promotes gastric cancer progression via stabilizing HuR to upregulate USP1 and Vimentin
Rong Li, Junyi Wang, Zhenfan Xie, et al.
Oncogene (2024) Vol. 43, Iss. 14, pp. 1033-1049
Open Access | Times Cited: 8
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway
Sichen Di, Wenjin Chen, Wei Yang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 6
Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing
Ji Zhang, Xinyu Xu, Hong‐Wei Deng, et al.
Pharmacology & Therapeutics (2024) Vol. 261, pp. 108697-108697
Closed Access | Times Cited: 5
Regulatory mechanism of circular RNA involvement in osteoarthritis
Yuke Zhang, Liting Liu, Kai Liu, et al.
Frontiers in Surgery (2023) Vol. 9
Open Access | Times Cited: 11
Biogenesis of circular RNAs, biological functions and their role in the development of osteoarthritis
Rogelio F. Jiménez-Ortega, Sergio Rafael Carrillo-Patiño, Fiordaliso Carolina Román-Carraro, et al.
Revista de Osteoporosis y Metabolismo Mineral (2025)
Open Access
Circ_0044362 Facilitates the Progression of Epithelial Ovarian Cancer via Enhancing HOXB4 Transcription to Activate the RUNX1/IGFBP3 Axis
Shuqi Ye, Han Wu, Junjiang Liu, et al.
Molecular Carcinogenesis (2025)
Closed Access
Research progress on circular RNA in the regulation of drug resistance in genitourinary cancers
Pengcheng Hu, Junxia Yao, Kejie Wang, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma
Kun Zhou, Dexin Wang, Xiaolin Du, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 3
CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway
Zhiyu Zhang, Jian‐Hao Xu, Jianglei Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect
Kaihua Xue, Yifan Jiang, Ji‐Yu Bai, et al.
Redox Report (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Non-coding RNAs in renal cell carcinoma: Implications for drug resistance
Yiqi Liu, Hu Zhang, Yuan Fang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 115001-115001
Open Access | Times Cited: 7
Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics
Yunxia Wang, Xiaolin Liu, Luyao Gong, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 23, pp. 2937-2955
Closed Access | Times Cited: 7
Circular RNAs: a small piece in the heart failure puzzle
Reza Eshraghi, Davood Shafie, Arash Raisi, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 3
Closed Access | Times Cited: 2
Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
Shengting Wang, Yufang Wang, Yue Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
Chunjie Huang, Pooya Esfani Sarafraz, Parisa Enayati, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
hsa_circ_0003596, as a novel oncogene, regulates the malignant behavior of renal cell carcinoma by modulating glycolysis
QingZhi Xie, FuQiang Qin, Lihui Luo, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Integration analysis of PLAUR as a sunitinib resistance and macrophage related biomarker in ccRCC, an in silicon and experimental study
Qiwei Yang, Fangdie Ye, Lin Li, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access | Times Cited: 1
Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis
Tengyu Jin, Haoyuan Wang, Yuelin Liu, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 3, pp. 313-335
Closed Access | Times Cited: 1
Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance
Di Zheng, Jinzhuo Ning, Yuqi Xia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma
Shuang Qin, Yuting Wang, Peijun Wang, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Reversing Sunitinib Resistance Facilitated by ITGA1 Through the PI3K/Akt/Bcl-2 Pathway Using Nano Co-Delivery System in Renal Cell Carcinoma
Suxian Hu, Yi Duan, Liting Wang, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 3, pp. 500-512
Closed Access
Page 1 - Next Page

Scroll to top